These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25085065)

  • 1. Nickel allergy in a patient with a nitinol stent in the superficial femoral artery.
    D'Arrigo G; Giaquinta A; Virgilio C; Davì A; Pierfrancesco V; Veroux M
    J Vasc Interv Radiol; 2014 Aug; 25(8):1304-6. PubMed ID: 25085065
    [No Abstract]   [Full Text] [Related]  

  • 2. Superficial femoral artery nitinol stent in a patient with nickel allergy.
    Jetty P; Jayaram S; Veinot J; Pratt M
    J Vasc Surg; 2013 Nov; 58(5):1388-90. PubMed ID: 23611713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial.
    Laird JR; Jain A; Zeller T; Feldman R; Scheinert D; Popma JJ; Armstrong EJ; Jaff MR;
    J Endovasc Ther; 2014 Apr; 21(2):202-12. PubMed ID: 24754279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crushed stent with acute occlusion in superficial femoral artery after enhanced external counterpulsation.
    Suh Y; Ko YG; Lee SH; Kim MD; Choi D
    JACC Cardiovasc Interv; 2014 Oct; 7(10):e141-2. PubMed ID: 25240552
    [No Abstract]   [Full Text] [Related]  

  • 5. German multicenter real-world registry of stenting for superficial femoral artery disease: clinical results and predictive factors for revascularization.
    Krankenberg H; Tübler T; Sixt S; Fischer M; Schmiedel R; Schulte KL; Balzer JO; Kieback A; Fiehn E; Wittenberg G; Ali T; Tiefenbacher C; Jahnke T; Steinkamp HJ; Wegscheider K; Treszl A; Ingwersen M; Zeller T
    J Endovasc Ther; 2014 Aug; 21(4):463-71. PubMed ID: 25101571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.
    Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Cao AY; Jaff MR;
    J Endovasc Ther; 2012 Feb; 19(1):1-9. PubMed ID: 22313193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral Vascular Stent Infection: Case Report and Review of Literature.
    Whitcher GH; Bertges DJ; Shukla M
    Ann Vasc Surg; 2018 Aug; 51():326.e9-326.e15. PubMed ID: 29775656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-radial bilateral iliac artery stenting.
    Harruna S; Jacobs ES; White CJ
    Vasc Med; 2013 Aug; 18(4):200-3. PubMed ID: 23945043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions.
    Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic hypersensitivity reaction to endovascular stainless steel stent.
    Univers J; Long C; Tonks SA; Freeman MB
    J Vasc Surg; 2018 Feb; 67(2):615-617. PubMed ID: 29248243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-month experience with the GORE® TIGRIS® Vascular Stent in the superficial femoral and popliteal arteries.
    Piorkowski M; Freitas B; Steiner S; Botsios S; Bausback Y; Scheinert D; Schmidt A
    J Cardiovasc Surg (Torino); 2015 Feb; 56(1):89-95. PubMed ID: 25410147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restenosis after stent implantation for superficial femoral artery disease in patients treated with cilostazol.
    Soga Y; Iida O; Hirano K; Suzuki K; Yokoi H; Nobuyoshi M
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):541-8. PubMed ID: 21805619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Pearl G; Theune B; Black S
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Hohman S; Pearl G; Theune B
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subintimal angioplasty with a true reentry device for treatment of chronic total occlusion of the arteries of the lower extremity.
    Aslam MS; Allaqaband S; Haddadian B; Mori N; Bajwa T; Mewissen M
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):701-6. PubMed ID: 20824749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored use of transradial access for above-the-knee angioplasty.
    Lorenzoni R; Lisi C; Corciu A; Lazzari M; Bovenzi F
    J Endovasc Ther; 2014 Oct; 21(5):635-40. PubMed ID: 25290790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of sex on angioplasty and primary stenting for femoropopliteal occlusive disease: results of the DURABILITY II trial.
    Tadros RO; Faries PL; Rocha-Singh KJ; Kim Sy; Malik RK; Ellozy SH; Marin ML; Vouyouka AG
    Ann Vasc Surg; 2014 Jan; 28(1):1-9. PubMed ID: 24189009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease.
    Lammer J; Bosiers M; Zeller T; Schillinger M; Boone E; Zaugg MJ; Verta P; Peng L; Gao X; Schwartz LB
    J Vasc Surg; 2011 Aug; 54(2):394-401. PubMed ID: 21658885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.